Kevin C. Gorman

2016

In 2016, Kevin C. Gorman earned a total compensation of $5.3M as President and Chief Executive Officer at Neurocrine Biosciences, a 6% increase compared to previous year.

Compensation breakdown

Bonus$337,440
Option Awards$2,202,729
Salary$592,000
Stock Awards$2,114,413
Other$43,076
Total$5,289,658

Gorman received $2.2M in option awards, accounting for 42% of the total pay in 2016.

Gorman also received $337.4K in bonus, $592K in salary, $2.1M in stock awards and $43.1K in other compensation.

Rankings

In 2016, Kevin C. Gorman's compensation ranked 1,485th out of 14,075 executives tracked by ExecPay. In other words, Gorman earned more than 89.4% of executives.

ClassificationRankingPercentile
All
1,485
out of 14,075
89th
Division
Manufacturing
509
out of 5,489
91st
Major group
Chemicals And Allied Products
142
out of 1,895
93rd
Industry group
Drugs
97
out of 1,538
94th
Industry
Biological Products, Except Diagnostic Substances
19
out of 279
93rd
Source: SEC filing on April 20, 2017.

Gorman's colleagues

We found five more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2016.

2016

Timothy Coughlin

Neurocrine Biosciences

Chief Financial Officer

2016

Christopher O'Brien

Neurocrine Biosciences

Chief Medical Officer

2016

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

2016

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2016

Kyle Gano

Neurocrine Biosciences

Chief Business Development Officer

News

You may also like